|
|
||||||||
J Thorac Cardiovasc Surg 2000;120:813-815
© 2000 The American Association for Thoracic Surgery
Brief Communications |
From the Department of Medicine, Division of Rheumatology,a and Department of Pathology and Cardiovascular Institute,b Mount Sinai School of Medicine, New York, NY.
Abstract presented at the American College of Rheumatology National Meeting, Boston, Mass, November 1999.
Address for reprints: Leslie D. Kerr, MD, Box 1244, Division of Rheumatology, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029-6574 (E-mail: daniel.calto{at}mssm.edu).
Although giant cell arteritis (GCA) affecting the aorta has been well described, its incidence as a complication of temporal arteritis has been considered infrequent.
1 Aortic dissection and aneurysm rupture were noted as rare, catastrophic sequelae occurring in patients with a previously established diagnosis of temporal arteritis
2 who had symptoms referable to the cranial arteries or upper extremity claudication.
In contrast, we describe 19 patients who presented, over a 4-year period, with thoracic aneurysms, abdominal aneurysms, or both, caused by active giant cell aortitis documented histopathologically. Only one patient had a history of temporal arteritis before aortic repair. The others lacked vascular symptoms.
Our experience suggests that active aortitis caused by occult GCA occurs more commonly than has been previously appreciated and may represent an important clinical variant of this disease. Efforts to improve recognition of giant cell aortitis to define optimal treatment strategies are warranted.
Patients and methods
A total of 1069 cases of aortic aneurysm repair or replacement performed between 1994 and 1998 were reviewed, in which 19 cases of active giant cell aortitis confirmed histopathologically were identified. All tissues reviewed were obtained at the time of surgery and were routinely processed for hematoxylin and eosin staining, as well as Gram staining, acid-fast staining, and fungal staining. The pathologic diagnosis of GCA was based on the finding of focal areas of medial necrosis surrounded by a granulomatous-like inflammatory reaction. Occasional multinucleated giant cells were present at the periphery of the necrotic areas. The necrotic areas were devoid of cells and contained compacted elastic fibers. The intima and adventitia were not usually involved(Fig 1).
|
|
Symptoms referable to the cranial arteries, such as scalp tenderness, jaw claudication, extremity claudication, vision loss, or temporal artery tenderness were not mentioned. The mean duration of onset of symptoms was approximately 2.2 years.
The most common physical finding consisted of a new murmur (14/19), with aortic insufficiency confirmed in 9 of 19 patients by echocardiography, cardiac catheterization, or both. Hypertension was present in 6 of 19 patients during the perioperative period. Sedimentation rates were not obtained in any patient. All aneurysms were classified preoperatively as atherosclerotic.
At the time of surgery, 17 of 19 had thoracic aortic aneurysms involving the ascending portion of the aorta. Two of these patients had acute dissection. Six of 19 had aneurysms of both the thoracic and abdominal aortas, and 2 of 19 had aneurysms of the abdominal aorta alone. Of the 9 aortic valves replaced, none had valvulitis. All patients had resection of the aneurysm and graft placement. No mention was made of any unusual gross operative findings indicative of giant cell aortitis at the time of surgery. There was no postoperative mortality, and all patients were discharged home without the use of steroids or immunosuppressive agents, because the importance of the histopathology was not appreciated and rheumatologic consultations were not sought.
Follow-up and outcome
The duration of follow-up varied from 1 to 4 years. During this period, there were two sudden deaths. The exact cause of death, however, could not be ascertained in either case. Nine patients are alive; of these, two are symptomatic.
Discussion
These 19 cases of tissue-documented active giant cell aortitis necessitating surgical intervention define a subgroup of patients with GCA whose active aortitis affecting the thoracic aorta is clinically occult, who lack symptoms referable to the cranial arteries, who have no history of temporal arteritis, and whose outcomes may be catastrophic.
Our experience is similar to that of previous authors. Brack and colleagues
3 described two clinical patterns of GCA consisting of cranial arteritis and large-vessel GCA. Their subgroup of patients with large-vessel disease had upper-extremity claudication or cardiovascular symptoms only. Evans and colleagues
1 described a markedly increased incidence of thoracic aortic aneurysms in their cohort of patients with biopsy-proven GCA compared with an age-matched population. Liu and colleagues,
4 in a review of 24 patients with thoracic aortic dissection caused by giant cell aortitis documented histopathologically, found that 11 of 24 had no prior symptoms of temporal arteritis and received no diagnosis until their catastrophic illness. Lie
5 described 72 patients with biopsy- or autopsy-documented active giant cell aortitis or extracranial GCA. Twenty-five percent of these patients had no symptoms referable to the cranial arteries. At surgery or autopsy, active giant cell aortitis affecting the aortic arch and ascending aorta predominated in 39%, which is similar to what we found in our patients.
Although incomplete, our follow-up data are suggestive of a poor outcome subsequent to successful surgical repair. Because GCA is a systemic disease, it is unlikely that aortic repair, although life-saving in the short term, is curative. Unfortunately, despite histopathologic documentation of active aortitis rather than atherosclerosis alone, none of these patients received either steroids or immunosuppressive therapy because the importance of the histopathology documenting active vasculitis was not appreciated, and rheumatologic input was not obtained.
Further study is required to define the optimal immunosuppressive regimen and is dependent on improved recognition of aortitis by the surgeons involved in these patients' care.
Acknowledgments
We thank Drs K. Dowling, S. Flagg, R. Sathynarayanan, and J. Weintraub for their assistance with data retrieval on this project.
References
This article has been cited by other articles:
![]() |
P. A. MERKEL Noninfectious Ascending Aortitis: Staying Ahead of the Curve J Rheumatol, October 1, 2009; 36(10): 2137 - 2140. [Full Text] [PDF] |
||||
![]() |
K. P. LIANG, V. R. CHOWDHARY, C. J. MICHET, D. V. MILLER, T. M. SUNDT, H. M. CONNOLLY, C. S. CROWSON, E. L. MATTESON, and K. J. WARRINGTON Noninfectious Ascending Aortitis: A Case Series of 64 Patients J Rheumatol, October 1, 2009; 36(10): 2290 - 2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pacini, O. Leone, S. Turci, N. Camurri, F. Giunchi, G. N. Martinelli, and R. Di Bartolomeo Incidence, Etiology, Histologic Findings, and Course of Thoracic Inflammatory Aortopathies Ann. Thorac. Surg., November 1, 2008; 86(5): 1518 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haddad, I. El-Rassi, F. G. Haddad, R. Nemnoum, and V. A. Jebara Aorto-Atrial Fistula 10 Days After Dissection Repair in Giant Cell Arteritis Ann. Thorac. Surg., November 1, 2008; 86(5): 1672 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Blumstein, L. D. Kerr, and J. T. Fallon Giant cell aortitis with histopathologic and clinical response to steroid therapy: A case report J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1467 - 1468. [Full Text] [PDF] |
||||
![]() |
N. A. Charokopos, P. Antonitsis, E. Rouska, I. Kostopoulos, A. Charaf, and P. K. Spanos Cartilaginous and osseous metaplasia with bone marrow formation in the aortic valve of a patient with giant cell aortitis. Ann. Thorac. Surg., May 1, 2006; 81(5): 1877 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gelsomino, S. Romagnoli, F. Gori, G. Nesi, C. Anichini, C. Sorbara, P. Stefano, and G. F. Gensini Annuloaortic Ectasia and Giant Cell Arteritis Ann. Thorac. Surg., July 1, 2005; 80(1): 101 - 105. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |